Plus Therapeutics Inc (NAS:PSTV) Stock News, Headlines & Updates
Plus Therapeutics Inc Stock News from GuruFocus
- 1
Jul 02, 2024
Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer
Marketwired • 7:00am
Jun 07, 2024
Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT
Marketwired • 7:00am
May 17, 2024
Plus Therapeutics Announces New Employment Inducement Grants
GlobeNewswire • 5:00pm
Plus Therapeutics Announces New Employment Inducement Grants
Marketwired • 4:00pm
May 16, 2024
Plus Therapeutics Inc (PSTV) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress Amid Financial Adjustments
GuruFocus Research • 1:05am
Q1 2024 Plus Therapeutics Inc Earnings Call Transcript
GuruFocus Research • 11:18pm
May 13, 2024
Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024
Marketwired • 7:00am
May 09, 2024
Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial
GlobeNewswire • 11:00am
Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial
Marketwired • 11:00am
May 08, 2024
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
GlobeNewswire • 5:00pm
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
Marketwired • 5:00pm
May 06, 2024
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
Marketwired • 7:00am
Apr 22, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news